| Tuesday, October 30, 2007 | ||
| 7:15 a.m. - 8:45 a.m. | Educational Session 301 Room 515A Intracranial SRS Physics/ Treatment Planning |
Sanford Lee Meeks, Ph.D., M.D. Anderson Cancer Center-Orlando, Orlando, Fla. David M. Shepard, Ph.D., Swedish Cancer Institute, Seattle |
| 7:15 a.m. - 8:45 a.m. | Educational Session 302 Room 404 Cervical Cancer- Practical Management Issues |
Beth A. Erickson, M.D., Medical College of Wisconsin, Milwaukee |
| 7:15 a.m. - 8:45 a.m. | Educational Session 303 Interactive Session Room 511 Challenging Cases in GI Malignancy |
Joel E. Tepper, M.D., UNC-CH School of Medicine, Chapel Hill, N.C. Jordan D. Berlin, M.D., Vanderbilt University, Nashville, Tenn. Elin R. Sigurdson, M.D., Ph.D., Fox Chase Cancer Center, Philadelphia |
| 7:15 a.m. - 8:45 a.m. | Educational Session 304 Room 406 Hodgkin's Disease and Clinical Trials |
Richard T. Hoppe, M.D., Stanford University, Stanford, Calif. Lena Specht, M.D., Ph.D., Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark |
| 7:15 a.m. - 8:45 a.m. | Educational Session 305 Room 515B Low Dose Rate Prostate Brachytherapy |
Louis Potters, M.D., South Nassau Communities Hospital, Oceanside, N.Y. Mack Roach III, M.D., UCSF Comprehensive Cancer Center, San Francisco Katsuto Shinohara, M.D., University of California, San Francisco, San Francisco |
| 7:15 a.m. - 8:45 a.m. | Educational Session 306 Room 409 Molecular Aspects of Cancer Biology: Techniques and Concepts |
Elaine M. Zeman, Ph.D., University of North Carolina School of Medicine, Chapel Hill, N.C. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 307 Room 403 IMRT II: Clinical and Radiobiology Aspects |
Bulent Aydogan, Ph.D., University of Chicago, Chicago Joseph O. Deasy, Ph.D., Washington University School of Medicine, St. Louis |
| 7:15 a.m. - 8:45 a.m. | Educational Session 308 Room 408 Advanced NSCLC: Using All the Tools (Imaging, Motion Correction, and IMRT) Promises and Pitfalls- A Case Based Approach |
Ellen D. Yorke, Ph.D., Memorial Sloan-Kettering Cancer Center, New York Aaron M. Allen, M.D., Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston Craig W. Stevens, M.D., Ph.D., H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 309 Room 405 Current Treatment and Controversies in Childhood Brain Tumors |
Nancy J. Tarbell, M.D., Massachusetts General Hospital, Boston Thomas E. Merchant, D.O., Ph.D., St. Jude Children's Research Hospital, Memphis, Tenn. |
| 7:15 a.m. - 8:45 a.m. | Educational Session 310 Interactive Session Room 502 Head and Neck Case Presentations |
Kenneth Shung Hu, M.D., Continuum Cancer Centers of New York, Beth Israel Medical Center, St. Luke’s and Roosevelt Hospitals and The New York Eye and Ear Infirmary, Albert Einstein College of Medicine, New York Mark Persky, M.D., Beth Israel Medical Center, New York Ezra Cohen, M.D., University of Chicago, Chicago Avraham Eisbruch, M.D., University of Michigan Medical Center, Ann Arbor, Mich. David I. Rosenthal, M.D., M.D. Anderson Cancer Center, Houston |
| 9:00 a.m. - 9:45 a.m. | Special Lecture Concourse Hall |
Tabareé Vazquez, M.D., President of Uruguay |
| 9:45 a.m. - 11:00 a.m. | Awards Ceremony Concourse Hall |
|
| 11:15 a.m. - 12:45 p.m. | Poster Discussion 3 Room 515B Lung - PET/SBRT/Pneumonitis |
Co-moderators: Indrin Chetty Mitchell Machtay |
| 11:15 a.m. - 12:45 p.m. | Poster Discussion 4 Room 518 CNS |
Co-moderators: Bernadine Donahue Jonathan Knisely |
| 11:15 a.m. - 12:45 p.m. | Scientific Session F Concourse Hall Breast I - PBI and Prognosis for Outcome |
Co-moderators: |
| 41 - Breast Magnetic Resonance Imaging in the Management of Early Breast Cancer: Implications for Partial Breast Irradiation | Rahul Tendulkar | |
| 42 - Accelerated Partial Breast Irradiation with Multi-catheter Brachytherapy: Local Control, Side Effects and Cosmetic Outcome for 274 Patients. Results of the German-Austrian Multi-centre Trial | Oliver Ott | |
| 43 - Image Guidance for External Beam Partial Breast Irradiation | Sasha Wahab | |
| 44 - Phase I/II Trial of Partial Breast Irradiation with Concurrent Dose-dense Doxorubicin and Cyclophosphamide (ddAC) Chemotherapy in Early Stage Breast Cancer: Report of Skin Toxicity and Cosmetic Outcome | Richard Cedric Zellars | |
| Discussant: Alphonse Taghian |
||
| 45 - Breast Cancer Subtype Approximated by ER, PR, and Her2 Receptors is Associated with Local-regional and Distant Failure after Breast-conserving Therapy | Paul Nguyen |
|
| 46 - Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast Cancer | Bruce Haffty | |
| 47 - Breast Cancer after Supradiaphragmatic Irradiation for Hodgkin’s Disease; Risk Analysis and Possible Surveillance Strategies | Kevin Hughes | |
| 48 - A Long-term Study of Radiation Therapy in T1-2 Node-negative Breast Cancer Patients Related with Number of Axillary Nodes Examined | Patricia Tai | |
| 11:15 a.m. - 12:45 p.m. | Scientific Session G Room 404 Quality of Life |
Co-moderators: Clair Beard George Perkins |
| 49 - Comparison of Health Related Quality of Life (HRQOL) in Men Treated with Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer | Varagur Venkatesan | |
| 50 - A Validation Study to Examine the Correlation Between Possession of Variants in the ATM Gene with the Development of Erectile Dysfunction in Prostate Cancer Patients Treated with Radiotherapy | Barry Rosenstein | |
| 51 - Urinary Morbidity after Permanent Prostate Brachytherapy with Dose Escalation to SPECT/CT Identified BTV Reported by American Brachytherapy Society (ABS) Guidelines | Rodney Ellis | |
| 52 - RTOG 0215 Treatment of Erectile Dysfunction (ED) in Patients Treated with Neoadjuvant and Concurrent Androgen Deprivation (AD) and Radiotherapy (RT) for Prostate Cancer (PC) | Deborah Watkins Bruner | |
| 53 - Can External Beam Radiotherapy for Prostate Cancer Help Improve Urinary Symptoms in Men with High IPSS Scores? | Renuka Malik | |
| 54 - Impact of Prostate Volume as a Predictor of Urinary Incontinence Following Radioactive Seed Implantation for Prostate Cancer | Grace Fan | |
| 55 - Quality of Life in Patients with Painful Bone Metastases Participating in a Randomized Trial: A Mixed Model Analysis on End-of-life Issues | Yvette Van der Linden | |
| 56 - Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review | Alysa Fairchild | |
| 57 - Pain Flare Following Radiotherapy for Painful Bone Metastases: A Joint Effort of Three Cancer Centres to Determine the Incidence | Amanda Hird | |
| 11:15 a.m. - 12:45 p.m. | Scientific Session H |
Co-moderators: Robert Lavey Zelig Tochner |
| 58 - Local-regional Tumor Progression after Radiation Therapy Influences Overall Survival in Pediatric Patients with Neuroblastoma | Atmaram Pai Panandiker |
|
| 59 - Excellent Local Control from Radiation Therapy for High Risk Neuroblastoma |
Heather Gatcombe | |
| 60 - A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-grade Glioma: 5-year Disease Control and Functional Outcomes |
Thomas Merchant | |
| 61 - Pediatric, Intracranial, Low-grade Glioma; 20-year Experience with Long-term Follow-up at the Mayo Clinic | Nadia Laack | |
| 62 - Long-term Outcomes for Pediatric Low-grade Hypothalamic/Chiasmatic Gliomas Treated on Phase II Chemotherapy Trial |
Kavita Mishra | |
| 63 - Intensity Modulated Radiation Therapy with use of Cone-down Boost in Treatment of Pediatric Head and Neck Rhabdomyosarcoma |
Mark McDonald | |
| 64 - Image Guidance in Whole Ventricular Irradiation Treatment Planning |
Darlene Gabeau-Lacet | |
| 65 - Early Results of a Prospective Study Delivering Limited Margin Radiotherapy for Pediatric Patients with Rhabdomyosarcoma |
Chia-ho Hua | |
| 66 - The Dosimetric Impact of Inter- and Intra-fractional Motion in Pediatric Neuroradiotherapy |
Chris Beltran | |
| 11:15 a.m. - 12:45 p.m. | Scientific Session I Room 406 Biology I - Stem Cells |
Co-moderators: |
| 67 - Establishment of Radiation-resistant Stem-like Esophageal Cancer Cells and Apoptotic Gene Targeting by Telomerase-specific Oncolytic Adenovirus | Xiaochun Zhang | |
| 68 - Analyzing the Sensitivity of Breast Cancer Stem Cells to Ionizing Radiation and Chemotherapyv | Maximilian Diehn | |
| 69 - Effects of Irradiation and Hematopoetic Stem Cell Transplantation on Airway Hyperreactivity | Jennifer Jonesv | |
| 70 - Adult Hepatic Progenitor Cells Engraft and Regenerate in Irradiated Rat Liversv | HongChao Zhou | |
| 71 - Mobilization of Bone Marrow Stem Cell Populations as a Result of Unopposed Estrogen: A Mechanism for Estrogen-mediated Angiogenesis | Michael Chan | |
| 72 - The Effect of Radiation on Tumorigenesis and Clonogenic Survival of Breast Cancer Stem Cells | Kathryn Huber | |
| 73 - Cancer Cells Survive Chemoradiotherapy Through Upregulation of a Stem Cell Signaling Pathway, Sonic Hedgehog, and Render Multi-drug Resistancev | K.S. Clifford Chao | |
| 74 - Intraesophageal Administration of Manganese Superoxide Dismutase Plasmid/liposomes (MnSOD-PL) Pre-irradiation Results in Increased Engraftment of Bone Marrow Progenitors of Esophageal Stem Cells | YunYun Nie | |
| Discussant: Richard Hill |
||
| 11:15 a.m. - 12:45 p.m. | Scientific Session J Room 502 Image Registration, Treatment Planning and Dosimetry |
Co-moderators: Lei Dong Jeffrey Siebers |
| 75 - 4D-CT Treatment Planning Tools using Deformable Image Registration | Sanjiv Samant | |
|
76 - Patient Positioning using a Fast Robust 2D-3D Registration Strategy with a Registration Quality Evaluator |
Jian Wu | |
| 77 - Toward Clinical Implementation of Adaptive Treatment Planning: Auto-propagation of Contours from Planning CT to Cone Beam CT Images | Jing Wang | |
| 78 - A Multi-institution Deformable Registration Accuracy Study | Kristy Brock | |
| 79 - Cone Beam CT Image Guidance for Intra-cranial Stereotactic Treatments: Comparison with a Frame Guided Set-up | Laura Masi | |
| 80 - Additional Doses to Critical Organs from CBCT Scan in Image Guided Radiation Therapy | George Ding | |
| 81 - Wide Range and High Spatial Resolution In Vivo Dosimetory Using Ultraminiature Plastic Scintillator with Pulse Couting Method | Masayori Ishikawa | |
82 - Dosimetric Evaluation of Heterogeneity Corrections for RTOG 0236: Hypofractionated Radiotherapy of Inoperable Stage I/II Non-small Cell Lung Cancer |
Ying Xiao | |
| 83 - Advanced Mixed Beam Treatment Techniques for Breast and Head and Neck Cancers | C.M. Charlie Ma | |
| 11:15 a.m. - 12:45 p.m. | Educational Session 311 The Theater Management of Primary, Refractory and Recurrent Diffuse Large B Cell and Other Aggressive Lymphomas |
David C. Hodgson, M.D., M.P.H., Princess Margaret Hospital, Toronto, Ontario, Canada Richard W. Tsang, M.D., Princess Margaret Hospital, Tornoto, Ontario, Canada Mary Gospodarowicz, M.D., Princess Margaret Hospital, Toronto, Ontario, Canada Andrea K. Ng, M.D., M.P.H., Brigham and Women's Hospital, Boston |
| 11:15 a.m. - 12:45 p.m. | Educational Session 312 Room 515A Breaking Barriers to Cancer Care: The Cancer Disparity Research Partnership |
Michael L. Steinberg, M.D., Santa Monica Cancer Treatment Center, Santa Monica, Calif. Patrick D. Maguire, M.D., New Hanover Radiation Oncology, Wilmington, N.C. Daniel G. Petereit, M.D., John T. Vucurevich Regional Cancer Care Institute, Rapid City, S.D. Allen Fremont, M.D., Ph.D., University of California Los Angeles Department of Medicine, Los Angeles Nell Griffith Forge, Ph.D., M.P.H., Rand Corporation, Santa Monica, Calif. |
| 12:45 p.m.- 1:45 p.m. | Business Meeting and Luncheon Petree Hall |
|
| 1:45 p.m. - 3:15 p.m. | Poster Discussion 5 Room 515B Genitourinary |
Co-moderators: Jeffrey Forman Srinivasan Vijayakumar |
| 1:45 p.m. - 3:15 p.m. | Poster Discussion 6 |
Co-moderators: Keith Cengel Andrew Lee |
| 1:45 p.m. - 3:15 p.m. | Scientific Session K Room 404 CNS I |
Co-moderators: Susan Ann Higgins John Suh |
| 84 - Tumor Regrowth between Surgery and Initiation of Radiation Therapy in Patients with Newly Diagnosed GBM | Andrea Pirzkall | |
| 85 - Radioimmunotherapy and Temozolomide in the Treatment of Glioblastoma Multiforme: A 20 Year Experience | Linna Li | |
| 86 - Adult Medulloblastoma: Retrospective Review of the M.D. Anderson Cancer Center Experience (1978-2006) | Marta Penas-Prado | |
| 87 - Evaluation of the RTOG Recursive Partitioning Analysis (RPA) Classification for Brain Metastases Among Patients Treated with Gamma-knife Radiosurgery for Brain Metastases | Robert Isaak | |
| 88 - Glioma Volume Growth: An Emerging Clinical Tool | Siddhartha Padmanabha | |
| 89 - Normalization of Tumor Vasculature and Alleviation of Edema by AZD2171, A Pan-VEGF Receptor Tyrosine Kinase Inhibitor in Glioblastoma Patients | Tracy Batchelor | |
| 90 - Feasibility of using Bevacizumab with Radiation Therapy in High Grade Gliomas | Ashwatha Narayana | |
| 91 - Safety and Efficacy of Bevacizumab as a Radiosensitizer in Malignant Glioma: Stereotactic Re-irradiation for Recurrences as a Pilot for Adjuvant Treatment | Philip Gutin | |
| 92 - Signal Transduction Molecules in Gliomas of all Grades | Tania Kaprealian | |
| 1:45 p.m. - 3:15 p.m. | Scientific Session L Room 502 Head and Neck II - Complications of Therapy |
Co-moderators: |
| 93 - Dose-response Relationships for the Submandibular Salivary Glands (SMSG) | Carol- Anne Murdoch-Kinch | |
| 94 - The Impact of Radiation-induced Morbidity on Health-related Quality of Life: Should we Really Focus on Xerostomia Alone? | Johannes Langendijk | |
| 95 - Dose to the Larynx Predicts for Swallowing Complications Following IMRT and Chemotherapy | Hale Caglar | |
| 96 - Associations between Radiation Doses to Pharyngeal Regions and Severe Late Toxicity in Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy -- An RTOG Analysis | Mitchell Machtay | |
| 97 - The Mean Radiation Dose in Pharyngheal Structures is a Strong Predictor of Acute and Persistent Swallowing Dysfunction and Quality of Life in Head and Neck Radiotherapy |
Patricia Doornaert | |
| Discussant 93-97: Chris Terhaard |
||
| 98 - Radiation Therapy versus Surgery in Patients with T1N0 Squamous Cell Carcinoma of the Glottic Larynx - A Population Based Study on Outcomes and the Risks of Secondary Malignancies | Gopal Sachdeva | |
| 99 - Reduced Incidence of Second Head and Neck Cancers in Patients Treated with External Beam Radiotherapy for Squamous Cell Carcinoma of the Head and Neck: A SEER Database Analysis | Kyle Rusthoven | |
| 100 - Subacute Central Nervous System Morbidity after Proton Therapy and Carbon Ion Therapy Against Head and Neck Cancers and Skull Base Tumors: Impact of Sequential Evaluation by MR Imagings | Daisuke Miyawaki | |
| 1:45 p.m. - 3:15 p.m. | Scientific Session M Room 403 Lung I - Chemo RT/Predictors |
Co-moderators: Lilie Lin Kenneth Rosenzweig |
| 101 - RTOG 0324: A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-small Cell Lung Cancer (NSCLC): Correlation between EGFR Expression and the Patients’ Outcome | Ritsuko Komaki | |
| 102 - PET-based Assessment of Local Failure Patterns in Non-small Cell Lung Cancer (NSCLC) Treated with Definitive Radiotherapy | Sonal Sura | |
| Discussant 101- 102: Corey Langer |
||
| 103 - Quality of Life (QOL) Supercedes the Classic Predictors of Survival in Locally Advanced Non-small Cell Lung Cancer (NSCLC): An Analysis of Radiation Therapy Oncology Group (RTOG) 9801 | Nicolas Nicolaou | |
| 104 - Radiation Dose is an Independent Predictor for Overall Survival in Patients with Stage Iii Unresectable Non-small Cell Lung Cancer Treated by Radiation with and without Chemotherapy | Li Wang | |
| 105 - Non-smokers and Former Smokers at Increased Risk for Treatment Related Pneumonitis (TRP) in Chemoradiation Therapy for Non-small Cell Lung Cancer (NSCLC) | Hekun Jin | |
| 106 - Lung Perfusion Score can Predict Future Pulmonary Complications after Radiation Therapy in Patients with Lung Cancer | Isis Gayed | |
| 107 - Association of DNA Repair and Inflammatory Cytokines Gene Polymorphisms with Radiation-induced Toxicity in Lung Cancer | Li Zhang | |
| Discussant 103 - 107: Gregory Videtic |
||
| 1:45 p.m. - 3:15 p.m. | Scientific Session N Room 405 Biomarkers/Predictive Assays |
Co-moderators: Theodore Chung Amit Maity |
| 108 - Possession of Single Nucleotide Polymorphisms in a Series of Candidate Genes Correlates with Low Levels of Radiation-Induced Apoptosis and the Development of Severe Late Adverse Effects Following Curative Intent Radiotherapy | Mahmut Ozsahin | |
| 109 - Impact of Interstitial Fluid Pressure, Tumor Oxygenation, and Chemotherapy Drug Sequencing on Response to Neoadjuvant Chemotherapy and on Long-term Local Control in Women Treated for Locally Advanced Breast Cancer | Karen Hoffman | |
| 110 - In Vivo Imaging of Apoptosis by Annexin V Scintigraphy: Predictive Value for Treatment Outcome |
Marcel Verheij | |
| 111 - Potential use of Early Cytokine Changes as Surrogate Markers in Adults versus Children Following a Terrorist Event | Jacqueline Williams | |
| 112 - Cells Lacking the Polq Polymerase are more Sensitive to Ionizing Irradiation In Vitro and In Vivo | Julie Goff |
|
| 113 - Association between Rad-51 Levels and Survival in Patients with Glioblastoma Multiforme Treated with Radiation Therapy | Rachit Kumar | |
| 114 - MicroRNA Expression is Altered by Ionizing Radiation: A Novel Potential Therapeutic Target |
Nicole Simone | |
| 115 - Whole Genome Amplification Permits the Detection of Circulating Tumor-derived K-Ras Mutations in the Plasma of Patients Treated with Radiation Therapy | Harvey Mamon | |
| 116 - ATM Phosphorylation Kinetics as a Biological Reporter of Cellular Radiosensitivity | Amir Lavaf | |
| 1:45 p.m. - 3:15 p.m. | Scientific Session O Room 409 Biological Imaging/Clinical Outcomes Modeling |
Co-moderators: James Dempsey Timothy Zhu |
| 117 - Diffusion Tensor Imaging: A Possible Biomarker for Early Prediction of Delayed Radiation-induced Neurocognitive Changes in Cerebral Tumor Patients | Vijaya Nagesh | |
| 118 - Dynamic Imaging and Real-time Inferential Modeling of Liver Motion with External Surrogates and Fast-MRI | Warren D. Souza | |
| 119 - Feasibility of Incorporating Magnetic Resonance Spectroscopy Imaging (mrsi) in Radiotherapy Treatment Planning of Recurrent Gliomas | Jenghwa Chang | |
| 120 - Comparison of Liver Metastases Volumes on CT, MR and FDG PET Imaging to Pathological Resection using Deformable Image Registration | Laura Dawson | |
| 121 - A Prospective Study Comparing CT-based to PET/CT-based Radiation Treatment Planning | Kristin Bradley | |
| 122 - Realistic Cellular Oxygen Model Reveals High Potential Gains with Dose Painting and Offers a General Solution for Incorporating Cellular Distributions that Underlie Imaging Data | Steven Petit | |
| 123 - Monitoring Responses to Treatment with High-frequency Ultrasound In Vivo: Assessing Response to Radiation vs. Photodynamic Therapy in Melanoma Xenograft Tumours | Behzad Banihashemi | |
| 124 - Predicting Treatment Outcomes using a Genetic Algorithm | Olivier Gayou | |
| 125 - Investigation of a Support Vector Model to Predict Lung Radiotherapy (RT) Induced Pneumonitis (RP) | Shifeng Chen | |
| 1:45 p.m. - 3:15 p.m. | Educational Session 313 Interactive Session Room 408 Clinical and Technical Guidelines from ACR and ASTRO |
Laurie E. Gaspar, M.D., M.B.A., Univ of Colorado at Denver, Aurora, Colo. Robert D. Timmerman, M.D., University of Texas Southwestern, Dallas Beryl McCormick, M.D., Memorial Sloan-Kettering Cancer Center, New York Alan C. Hartford, M.D., Ph.D., Dartmouth-Hitchcock Medical Center, Lebanon, N.H. Terry J. Wall, M.D., J.D., St. Luke's Hospital of Kansas City, Kansas City, Mo. |
| 1:45 p.m. - 3:15 p.m. | Educational Session 314 Room 406 Evaluation and Management of Bladder Cancer |
William U. Shipley, M.D., Massachusetts General Hospital, Boston Anthony J. Zietman, M.D., Massachusetts General Hospital, Boston |
| 1:45 p.m. - 5:30 p.m. | Nurses Session 20 Room 501 Treatment and Care for the GYN Patient |
Patricia J. Eifel, M.D., M.D. Anderson Cancer Center, Houston Anjua Jhingran, M.D., M.D. Anderson Cancer Center, Houston Melissa Hamilton Draper, R.D., L.D., M.D. Anderson Cancer Center, Houston Monica Campbell, R.N., M.D. Anderson Cancer Center, Houston Paula Berner, B.S., C.M.D., M.D. Anderson Cancer Center, Houston |
| 3:30 p.m. - 5:00 p.m. | Educational Session 315 The Theater Lung Cancer- Small Cell |
Howard West, M.D., Swedish Cancer Institute, Seattle Walter J. Curran, M.D., Thomas Jefferson University Hospital, Philadelphia |
| 3:30 p.m. - 5:00 p.m. | Educational Session 316 Room 511 Cancer of the Esophagus |
Brian Czito, M.D., Duke University Medical Center, Durham, N.C. Christopher G. Willett, M.D., Duke University Medical Center, Durham, N.C. |
| 3:30 p.m. - 5:00 p.m. | Panel 11 Room 403 Proton Therapy This panel will explore the theoretical and practical basis for the use of proton therapy. particular emphasis will be paid to improving the therapeutic index of treatment, the socioeconomic impact of proton therapy, and new clinical and technical developments. |
Moderator: Stephen M. Hahn, M.D., University of Pennsylvania, Philadelphia Nancy P. Mendenhall, M.D., University of Florida, Gainesville, Fla. Timothy R. Williams, M.D., Boca Raton Community Hospital, Boca Raton, Fla. James McDonough, Ph.D., University of Pennsylvania, Philadelphia |
| 3:30 p.m. - 5:00 p.m. | Panel 12 Room 515A Practical Challenges to Incorporating Biological Imaging Modalitites into RT Planning The panel will address the issues for PET (both FDG and up-coming tracers) and for MRSI. |
Moderator: |
| 3:30 p.m. - 5:00 p.m. | Panel 13 Room 408 Masters in Radiation Oncology Every radiation oncologist sees a wide range of patients in practice, some of whom are relatively straight forward and some of whom are extraordinarily complex. Despite “evidence-based” medical decisions, there are times that the evidence-based decisions are trumped by anatomic issues or other associated co-morbid medical problems that may necessitate deviation from the norm. This panel is aimed at crystallizing a few such problems that are not hypothetical but real problems seen in the practice of expert radiation oncologists. |
Moderator: |
| 3:30 p.m. - 5:00 p.m. | Panel 14 Interactive Room 502 Post Operative Radiotherapy Following Prostatectomy: Now That We Know it Works, How Should We do it? In this panel session, radiotherapy following prostatectomy will be explored. The randomized trials supporting its use in men with high-risk features will be summarized. The patterns of recurrence following surgery will be reviewed. The specifics of technique (dose, volumes, etc.) will be highlighted. Several cases will be presented for discussion by the panelists and the audience. |
Moderator: |
| 5:00 p.m. - 6:30 p.m. | Presidential Poster Session and Reception Exhibit Hall Join us for refreshments while viewing more than 900 ASTRO posters in the exhibit hall and meet the presenting authors. |
|
Additional information will be posted periodically. Inquiries should be directed the Education Department.